1 Min Read
April 30 (Reuters) - Edwards Lifesciences Corp:
* EDWARDS GRANTED CE MARK FOR FIRST TRANSCATHETER TRICUSPID THERAPY Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.